LigaChem Biosciences shares up 9% on first patient dosing of ADC
Predicted impact: Low· Actual: +4.5% vs sector, volume 1.0× normal (5 trading days)
Same ADC first-dosing news as item 4; share move already reflected, lowered level.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.